Cedric Mercier

Marseille, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Therapy-related myeloid neoplasms after 177Lu-DOTATATE therapy for metastatic neuroendocrine neoplasia: CPX-351 consolidated by allogeneic stem cells transplantation as applicable therapeutic strategy.

Therapy-related myeloid neoplasms after 177Lu-DOTATATE therapy for metastatic neuroendocrine neoplasia: CPX-351 consolidated by allogeneic stem cells transplantation as applicable therapeutic strategy.

Journal: Leukemia & lymphoma
Published: April 12, 2023

Could daratumumab induce the maturation of plasmablasts in Plasmablastic lymphoma?-Potential therapeutic applications.

Could daratumumab induce the maturation of plasmablasts in Plasmablastic lymphoma?-Potential therapeutic applications.

Journal: European journal of haematology
Published: November 13, 2020

Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma.

Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma.

Journal: Leukemia & lymphoma
Published: January 05, 2020

Efficacy and safety of autologous stem cell transplantation after induction therapy with lenalidomide, bortezomib, and dexamethasone.

Efficacy and safety of autologous stem cell transplantation after induction therapy with lenalidomide, bortezomib, and dexamethasone.

Journal: European journal of haematology
Published: June 06, 2019

Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patients.

Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patients.

Journal: European journal of internal medicine
Published: April 01, 2019

Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen.

Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen.

Journal: Bone marrow transplantation
Published: August 27, 2018

Hematopoietic reconstitution after autologous hematopoietic stem cell transplantation: do CD45 (+) CD34 (+) CD38 (-) progenitors really matter in real life?

Hematopoietic reconstitution after autologous hematopoietic stem cell transplantation: do CD45 (+) CD34 (+) CD38 (-) progenitors really matter in real life?

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: March 15, 2018

A transcriptomic signature predicting septic outcome in patients undergoing autologous stem cell transplantation.

A transcriptomic signature predicting septic outcome in patients undergoing autologous stem cell transplantation.

Journal: Experimental hematology
Published: January 16, 2018

Vorinostat and Mithramycin A in combination therapy as an interesting strategy for the treatment of Sézary T lymphoma: a transcriptomic approach.

Vorinostat and Mithramycin A in combination therapy as an interesting strategy for the treatment of Sézary T lymphoma: a transcriptomic approach.

Journal: Archives of dermatological research
Published: March 01, 2017

Micafungin as primary antifungal prophylaxis in patients presenting with acute myeloid leukemia.

Micafungin as primary antifungal prophylaxis in patients presenting with acute myeloid leukemia.

Journal: Medecine et maladies infectieuses
Published: December 11, 2015

Yin and yang of cytidine deaminase roles in clinical response to azacitidine in the elderly: a pharmacogenetics tale.

Yin and yang of cytidine deaminase roles in clinical response to azacitidine in the elderly: a pharmacogenetics tale.

Journal: Pharmacogenomics
Published: November 12, 2015

Eradication of T315I mutation in chronic myeloid leukemia without third-generation tyrosine kinase inhibitor: a case report.

Eradication of T315I mutation in chronic myeloid leukemia without third-generation tyrosine kinase inhibitor: a case report.

Journal: Pharmacogenomics
Published: May 08, 2015
Showing 1-12 of 19

Last Updated: 09/26/2026